tm logo
CELAID THERAPEUTICS
Live/Registered
REGISTERED

on 12 Mar 2024

Last Applicant/ Owned by

Tokyo 113-8485

JP

Serial Number

79347683 filed on 18th May 2022

Registration Number

7324426 registered on 12th Mar 2024

in the Principal Register

Correspondent Address

Karen Lim

Fross Zelnick Lehrman & Zissu, P.C.

151 W 42nd St 17th floor

New York,NY 10036

Filing Basis

1. filing basis filed as 66 a

Disclaimer

"THERAPEUTICS"

CELAID THERAPEUTICS

Testing, inspection or research of pharmaceuticals, cosmetics or foodstuffs "THERAPEUTICS" Blood testing and analysis; provision of information on blood tests; providing medical information and consultation; blood bank services; rental of blood filtration units; medical services relating to the removal, treatment and processing of human blood, umbilical cord blood, human cells, stem cells and bo Read More

Classification Information


Class [044]
Medical, Beauty & Agricultural Services


Blood testing and analysis; provision of information on blood tests; providing medical information and consultation; blood bank services; rental of blood filtration units; medical services relating to the removal, treatment and processing of human blood, umbilical cord blood, human cells, stem cells and bone marrow

Class [042]
Computer & Software Services & Scientific Services


Testing, inspection or research of pharmaceuticals, cosmetics or foodstuffs

Class [040]
Treatment & Processing of Materials Services


Treatment and processing of human cells for others; treatment and processing of cells for medical use; cryogenic preservation; custom manufacture of pharmaceutical preparations for others; treatment and processing of blood and blood products

Class [005]
Pharmaceutical Products


Pharmaceutical preparations for the prevention and treatment of cancers; pharmaceutical preparations for the prevention and treatment of hematological malignancies; pharmaceutical preparations for the prevention and treatment of non-hematological malignancies; pharmaceutical preparations for the prevention and treatment of genetic disorders; pharmaceutical preparations for use as gene therapy agent; pharmaceutical preparations for use as regenerative medicine agent; cells for medical use; blood products for the prevention and treatment of cancers; blood products for the prevention and treatment of hematological malignancies; blood products for the prevention and treatment of non-hematological malignancies; blood products for the prevention and treatment of genetic disorders; blood products for use as gene therapy agent; blood products for use as regenerative medicine agent; blood for medical purposes; hemotropic agents for stimulation of cell function, gene therapy, cell therapy, and for use as blood substitutes; cellular function activating agents for medical purposes; reagents for medical use; cell preparations for the treatment of diseases and disorders; clinical diagnostic reagents; stem cells for medical purposes

Class [001]
Chemical Products


Chemical reagents for non-medical purposes, chemicals for use in the manufacture of pharmaceuticals; reagents for scientific and research use

Mark Details


Serial Number

No 79347683

Mark Type

No Service Mark

Attorney Docket Number

No CLDT 2309434

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

Yes

66A Current

Yes

Current Basis

No

No Basis

No

Design Code(s)

26.01.13 -

Two circles

26.01.16 -

Circles touching or intersecting

26.01.21 -

Circles that are totally or partially shaded

Description of Design Search

The mark consists of the stylized word "CELAID" with the letters "CELA" and "D" in black and the letter "I" in pink. The stylized word "THERAPEUTICS" appears below in black. To the left of the wording, the design of two irregular circles appears, with the lower circle in pink and the upper circle in blue. The overlapping area of the circles appears in purple.

Legal History


Show more

Status DateAction Taken
12th Mar 2024REGISTERED-PRINCIPAL REGISTER
12th Mar 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
13th Feb 2024NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
24th Jan 2024NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
24th Jan 2024NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
26th Dec 2023PUBLISHED FOR OPPOSITION
26th Dec 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
26th Dec 2023NOTIFICATION PROCESSED BY IB
06th Dec 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06th Dec 2023NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB